FEBS is one of the largest organisations in European life sciences. FEBS seeks to promote, encourage and support biochemistry, molecular cell biology, molecular biophysics and related areas throughout Europe. It publishes four scientific journals and funds an Annual Congress, Medals and Prizes, Research Fellowships, Advanced Courses, Workshops, Special Meetings and Travel Grants. FEBS also promotes scientific aid to disadvantaged economies, and action on education, women in science, science and society, and research funding. LINKS TO LATEST ISSUES: FEBS Journal, FEBS Letters, Molecular Oncology, FEBS Open Bio Latest Virtual and Special Issues FEBS has twin commitments to high-quality publications and the promotion of molecular biosciences. FEBS owns all its publications, from FEBS Journal to FEBS Letters, Molecular Oncology and FEBS Open Bio. They are published on our behalf by Wiley-Blackwell and Elsevier, who return most of the revenue to FEBS, which, as a not-for-profit academic organization, ploughs all the income into funding our diverse activities: FEBS fellowships; advanced courses and workshops; congresses; and aiding researchers in poorer countries. By publishing in FEBS journals and taking part in reviewing, you are both supporting high-quality science and helping provide an essential income stream to fund education and research. The proliferation of open access journals with ill-defined standards of peer review makes it more important than ever to publish in journals that bear the stamp of respected organizations and publishers.   |
|
Search:
|
